本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BioCryst制药

7.83
+0.03000.38%
盘后7.830.00000.00%19:24 EDT
成交量:128.92万
成交额:1,008.38万
市值:16.36亿
市盈率:-18.21
高:7.88
开:7.83
低:7.75
收:7.80
数据加载中...

公司资料

公司名字:
BioCryst制药
交易所:
NASDAQ
成立时间:
1986
员工人数:
580
公司地址:
4505 Emperor Boulevard,Suite 200,Durham,North Carolina,United States
邮编:
27703
电话:
传真:
919 859 1314
简介:
BioCryst Pharmaceuticals, Inc.是一家特拉华州公司,最初成立于1986年。该公司是一家全球性生物技术公司,致力于改善遗传性血管性水肿和罕见病患者的生活。该公司利用结构引导药物设计方面的专业知识,目标是开发一流或一流的口服小分子和注射蛋白疗法,以针对难以治疗的罕见疾病。

董事

名称
职位
Jon P. Stonehouse
Director, President and Chief Executive Officer
Robert A. Ingram
Director and Chairman of the Board
Fred E. Cohen
Director
George B. Abercrombie
Director
Kenneth B. Lee, Jr.
Director
Nancy J. Hutson
Director
Stanley C. Erck
Director

股东

名称
职位
Jon P. Stonehouse
Director, President and Chief Executive Officer
Lynne Powell
Senior Vice President and Chief Commercial Officer
Thomas R. Staab II
Senior Vice President, Chief Financial Officer, Treasurer and Principal Accounting Officer
William P. Sheridan
Senior Vice President and Chief Medical Officer
Yarlagadda S. Babu
Senior Vice President of Drug Discovery
Alane P. Barnes
Vice President, General Counsel and Corporate Secretary